Remedy Meds

Remedy Meds is an online telehealth platform that provides personalised medical weight loss treatment to patients in the United States. The company pairs Americans with state-licensed clinicians for virtual consultations and produces data-informed treatment plans, delivering care through video and chat rather than in-person visits.

Its principal offering is a GLP-1 weight loss treatment programme based on compounded medications, including Semaglutide and Tirzepatide. Members receive unlimited clinician-led care, monthly check-ins and dose adjustments. The company reports having written more than 1,200,000 prescriptions; among its members, the stated success rate is 94.6%, and the top responder recorded a weight loss of nearly 76 lbs over 12 months.

The service operates on a month-to-month subscription that accepts HSA and FSA payments, includes free 48-hour cold-chain FedEx delivery and, for eligible members, a weight loss warranty. Business activity sits at the intersection of telehealth, personalised medicine, virtual care delivery and compounded pharmaceuticals.